Oral antipyretic therapy: evaluation of benorylate, an ester of acetylsalicylic acid and paracetamol

Eur J Pediatr. 1975 Dec 9;121(1):15-20. doi: 10.1007/BF00464391.

Abstract

The capacity of benorylate, an ester of acetylsalicylic acid and paracetamol, to reduce fever in children was compared with that of the components as such or as a combination. The series of cases studied consisted of 66 patients between the ages of 4 months and 12 years with rectal temperatures above 38.5 degrees C. Temperatures were recorded at 15 and 20 min and 1, 2, 4 and 6 hrs after the administration of the drug. The antipyretic effect of combined acetylsalicylic acid (11 mg/kg) and paracetamol (14 mg/kg) was superior to the effect of benorylate with a dose of 25 mg/kg and even of 50 mg/kg as well as better than the effect of either drug alone. Acetylsalicylic acid (10 mg/kg) and paracetamol (12.5 mg/kg) alone produced a significantly greater antipyretic effect than benorylate with a dose of 25 mg/kg. Given in a dose of 35--40 mg/kg, benorylate seems to have a significant antipyretic effect. However, this effect is clearly smaller than that of either of its components, acetylsalicylic acid or paracetamol. Therefore benorylate is probably not suitable to be used as a general antipyretic agent in children.

Publication types

  • Comparative Study

MeSH terms

  • Acetaminophen / therapeutic use
  • Aspirin / therapeutic use
  • Body Temperature / drug effects
  • Child
  • Child, Preschool
  • Fever / drug therapy*
  • Humans
  • Infant
  • Salicylates / therapeutic use*
  • Time Factors

Substances

  • Salicylates
  • Acetaminophen
  • Aspirin